Gregory Shiferman - Senior Vice President, General Counsel and Secretary at Sage Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Senior Vice President, General Counsel and Secretary
Stock Symbol
SAGE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gregory Shiferman since 12/22/2023

Holdings reported by Gregory Shiferman for Sage Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20K $179K $8.96 Nov 1, 2024 Direct
Stock Option (Right to buy) 10K Nov 1, 2024 Direct Common Stock

Transactions reported by Gregory Shiferman for Sage Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.